Session: The Obesity and Diabetes Epidemic: The State of the Science and the Challenge to Public Health
3329.1: Monday, November 17, 2003: 4:30 PM-6:00 PM
The Obesity and Diabetes Epidemic: The State of the Science and the Challenge to Public Health
Preventing obesity and type 2 diabetes are two of the most important public health issues facing our nation. Immediate intervention is critical as the rates of these two diseases are increasing nationally at an alarming rate. Recent data suggest that both conditions may be prevented or reduced through lifestyle changes. Evidence about Overweight/Obesity document that between 1980 and 2000, the proportion of obese adult Americans doubled; approximately two-thirds of all American adults suffer from overweight and an even larger percentage of some ethnic or socioeconomic groups are affected; and 9 million children (15%) between the ages of 6 and 19 are labeled overweight. Obesity is a major risk factor for Type 2 diabetes and other chronic debilitating conditions including heart disease, cancer, and stroke. The estimated annual cost of obesity in the United States is $97 billion. Diabetes is the sixth leading cause of death and results in a serious burden for those affected and for society. More than 90% of persons with diabetes are Type 2. It affects both sexes, all ages, all ethnic groups and all educational levels but disproportionately impacts women and minorities. The estimated annual cost of diabetes in the United States is $ 132 billion. Speakers will discuss relevant research findings and challenges in addressing these interrelated issues; the impact of obesity and diabetes; efficacious and cost-effective preventive practices that can reduce the burden of these diseases; and will challenge public health professionals to put evidence-based interventions and policies into place.
Learning Objectives: At the end of the session, it is expected that participants will be able to: (1)Understand the relationship between obesity and diabetes and its effects on health outcomes (2)Identify barriers to weight control/weight loss (3)Identify risk factors of obesity and diabetes (4)Consider and promote population-based preventive approaches to addressing obesity and diabetes
See individual abstracts for presenting author's disclosure statement and author's information.
Panelist(s):Yvette Freeman
Geraldine Perry
Joshua A. Mott, PhD
Frances Ashe-Goins
Michelle D. Owens, PhD
John Miall
Judith Fradkin, MD
Moderator(s):Frances Ashe-Goins
Joshua A. Mott, PhD
4:30 PMIntroduction, Frances Ashe-Goins, RN; Joshua Mott, MA, PhD, EIS
4:35 PMState of the science: Diabetes and obesity in women, Judith Fradkin, MD *
4:55 PMPutting the science into action: Risk management policies in one community, John Miall *
5:10 PMThe public health perspective: The national diabetes and women action plan, Michelle Owens, PhD *
5:25 PMLiving with diabetes: Beating the odds, Yvette Freeman
5:40 PMClosing Remarks, Geraldine Perry, DrPH, RD
5:50 PMAudience Questions
Organized by:APHA-Science Board
Outside sponsors:Office of Women's Health, DHHS and the Office of Diabetes Translation, CDC
CE Credits:Pharmacy

The 131st Annual Meeting (November 15-19, 2003) of APHA